Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

96.16 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Q4 Earnings Review: Medical Devices & Supplies - Imaging, Diagnostics Stocks Led by GE HealthCare (NASDAQ:GEHC)
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at GE HealthCare (NASDAQ:GEHC) and its peers. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
1 Healthcare Stock on Our Watchlist and 2 to Brush Off
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
For those who appreciate growth without the sticker shock, LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is worth considering.
Discover LANTHEUS HOLDINGS INC, an undervalued growth gem. NASDAQ:LNTH is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing... 
Via Chartmill
Q4 Earnings Highs And Lows: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - imaging, diagnostics industry, including Lantheus (NASDAQ:LNTH) and its... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Lantheus' Pylarify Hit $1B in 2024 Sales
Via The Motley Fool
Earnings Scheduled For February 26, 2025
Via Benzinga
ResMed Among Top Stocks For Recent And Long-Term Profit Growth
A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue? 
Via Investor's Business Daily
3 Growth Stocks to Stash
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s... 
Via StockStory
Exposures COVID-19
Root And ZoomInfo Are Among Top 8 Mid-Cap Gainers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio?
Top mid-cap stock gainers in past week: Root, Bridge Investment Group, Huron Consulting, Medical Properties Trust, ZoomInfo Technologies, Lantheus Holdings, Alignment Healthcare, VSE. Analysts raise... 
Via Benzinga
Workday, ACM Research, ZoomInfo Technologies, CEVA, Intuit And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Lantheus (LNTH): A 10x Opportunity in Radiopharmaceuticals
Via The Motley Fool
What 4 Analyst Ratings Have To Say About Lantheus Holdings
Via Benzinga
Lantheus (LNTH) Shares Skyrocket, What You Need To Know
Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) jumped 19.8% in the morning session after the company delivered strong fourth-quarter 2024 results, with revenue and earnings... 
Via StockStory
Lantheus’s (NASDAQ:LNTH) Q4 Sales Top Estimates, Stock Soars
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 10.5% year on year to $391.1 million. On the other hand,... 
Via StockStory
Lantheus Reports Fourth Quarter and Full Year 2024 Financial Performance
From Lantheus Holdings, Inc.
Via GlobeNewswire
Earnings To Watch: Lantheus (LNTH) Reports Q4 Results Tomorrow
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be reporting earnings tomorrow before market hours. Here’s what you need to know. 
Via StockStory
NASDAQ:LNTH is not too expensive for the growth it is showing.
LANTHEUS HOLDINGS INC was identified as a growth stock that isn't overvalued. NASDAQ:LNTH is excelling in various growth indicators while maintaining a solid financial footing. 
Via Chartmill
Lantheus to Present at Upcoming Investor Conferences
From Lantheus Holdings, Inc.
Via GlobeNewswire
Despite its impressive fundamentals, NASDAQ:LNTH remains undervalued.
Uncover the potential of LANTHEUS HOLDINGS INC, an undervalued stock. NASDAQ:LNTH maintains a strong financial position and offers an appealing valuation. 
Via Chartmill
Lantheus to Host Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast on February 26, 2025, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting
From Lantheus Holdings, Inc.
Via GlobeNewswire
NASDAQ:LNTH is showing decent growth, but is still valued reasonably.
LANTHEUS HOLDINGS INC was identified as an affordable growth stock. NASDAQ:LNTH is showing great growth, but also scores well on profitability. At the same time it seems to be priced reasonably. 
Via Chartmill
Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New Board Member
From Lantheus Holdings, Inc.
Via GlobeNewswire
NASDAQ:LNTH is probably undervalued for the fundamentals it is displaying.
LANTHEUS HOLDINGS INC has a stellar value proposition. NASDAQ:LNTH not only scores well in profitability, solvency, and liquidity but also maintains a very reasonable price point. 
Via Chartmill
Why Lantheus Holdings Stock Got Thrashed on Tuesday
Via The Motley Fool
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Lantheus To Buy Evergreen Theragnostics For Over $1 Billion To Bolster Its Cancer Radiopharmaceutical Portfolio
Lantheus strengthens its radiopharmaceutical business with Evergreen and Life Molecular acquisitions, adding oncology and Alzheimer's diagnostics. 
Via Benzinga
Why NASDAQ:LNTH Is a Standout High-Growth Stock in a Consolidation Phase.
Based on a technical and fundamental analysis of NASDAQ:LNTH we ask: Is LANTHEUS HOLDINGS INC (NASDAQ:LNTH) on the Verge of a Major Breakout as a Strong Growth Stock? 
Via Chartmill
Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader
From Lantheus Holdings, Inc.
Via GlobeNewswire
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt
Deal opportunities abound: KKR & Co.'s stake in Maya; DuPont's electronics business; Ingevity's North Charleston site; and S&W Seed Company. 
Via Benzinga
Topics Government
Exposures Political
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.